OKYO PHARMA LIMITED
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 92.38B | ||||||
| 37.9B | ||||||
| 33.73B | ||||||
| 27.98B | ||||||
| 15.86B |
